Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6817 USD | +0.24% |
|
+0.24% | -4.56% |
Capitalization | 35.66M 30.6M 28.51M 26.52M 48.94M 3.07B 54.64M 344M 130M 1.44B 134M 131M 5.29B | P/E ratio 2023 |
3.59x | P/E ratio 2024 | -2.23x |
---|---|---|---|---|---|
Enterprise value | -13.2M -11.33M -10.55M -9.82M -18.12M -1.14B -20.23M -128M -48.13M -533M -49.52M -48.5M -1.96B | EV / Sales 2023 |
-0.06x | EV / Sales 2024 | 0.31x |
Free-Float |
79.05% | Yield 2023 * |
-
| Yield 2024 | 8.77% |
More valuation ratios
* Estimated data
More news
More press releases
1 day | +0.24% | ||
1 week | +0.24% | ||
Current month | +0.55% | ||
1 month | +26.26% | ||
3 months | +113.03% | ||
6 months | +0.92% | ||
Current year | -4.56% |
1 week | 0.68 | ![]() | 0.68 |
1 month | 0.51 | ![]() | 0.68 |
Current year | 0.25 | ![]() | 0.76 |
1 year | 0.25 | ![]() | 1.19 |
3 years | 0.25 | ![]() | 2.75 |
5 years | 0.25 | ![]() | 4.85 |
10 years | 0.25 | ![]() | 12.04 |
Manager | Title | Age | Since |
---|---|---|---|
Kara Cannon
CEO | Chief Executive Officer | 57 | 2023-09-04 |
Patricia Eckert
DFI | Director of Finance/CFO | 48 | - |
Dieter Schapfel
CTO | Chief Tech/Sci/R&D Officer | 61 | 2014-06-30 |
Director | Title | Age | Since |
---|---|---|---|
Kara Cannon
BRD | Director/Board Member | 57 | 2024-01-30 |
Bradley Radoff
BRD | Director/Board Member | 51 | 2022-01-02 |
Steven Pully
CHM | Chairman | 65 | 2023-10-25 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
0% | 293,477 M€ | +1.92% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.24% | +0.24% | -39.67% | -73.68% | 35.66M | ||
+3.62% | +6.18% | -16.44% | -13.99% | 77.97B | ||
-1.36% | -4.44% | -49.17% | -7.53% | 58.12B | ||
-1.78% | +5.10% | +23.50% | +28.64% | 54.74B | ||
+0.49% | +1.30% | +23.57% | +109.40% | 38.32B | ||
-0.06% | +10.97% | +116.40% | +141.66% | 19.41B | ||
-2.88% | -6.87% | -44.51% | -41.69% | 18.86B | ||
+0.31% | +9.13% | +78.83% | +804.62% | 18.77B | ||
-0.04% | -.--% | +72.36% | +138.68% | 14.02B | ||
-1.57% | -1.06% | +3.81% | -13.95% | 13.34B | ||
Average | -0.22% | +1.90% | +16.87% | +107.22% | 31.36B | |
Weighted average by Cap. | +0.22% | +1.56% | +6.42% | +73.50% |
2023 | 2024 | |
---|---|---|
Net sales | 31.06M 26.65M 24.83M 23.1M 42.63M 2.68B 47.59M 300M 113M 1.25B 117M 114M 4.61B | 31.91M 27.38M 25.51M 23.73M 43.79M 2.75B 48.89M 308M 116M 1.29B 120M 117M 4.74B |
Net income | 20.29M 17.41M 16.22M 15.09M 27.84M 1.75B 31.09M 196M 73.96M 819M 76.1M 74.52M 3.01B | -26.08M -22.37M -20.85M -19.4M -35.79M -2.25B -39.96M -252M -95.07M -1.05B -97.82M -95.79M -3.87B |
Net Debt | -75.38M -64.67M -60.26M -56.06M -103M -6.49B -115M -728M -275M -3.04B -283M -277M -11.19B | -48.86M -41.92M -39.06M -36.34M -67.05M -4.21B -74.87M -472M -178M -1.97B -183M -179M -7.25B |
More financial data
* Estimated data
Employees
131
Sector
Pharmaceuticals
Calendar
Date | Price | Change | Volume |
---|---|---|---|
25-07-18 | 0.6817 $ | +0.24% | 3,011 |
25-07-17 | 0.6801 $ | 0.00% | 85,447 |
25-07-16 | 0.6801 $ | -0.43% | 17,186 |
25-07-15 | 0.6830 $ | +0.08% | 9,721 |
25-07-14 | 0.6825 $ | +0.35% | 201,955 |
Delayed Quote OTC Markets, July 18, 2025 at 03:15 pm
More quotes- Stock Market
- Equities
- ENZB Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition